- Home
- DERM vs BTCS Comparison
DERM vs BTCS Comparison
Compare DERM & BTCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- BTCS
- Stock Information
- Founded
- DERM 2014
- BTCS 2008
- Country
- DERM United States
- BTCS United States
- Employees
- DERM N/A
- BTCS N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- BTCS Finance: Consumer Services
- Sector
- DERM Health Care
- BTCS Finance
- Exchange
- DERM Nasdaq
- BTCS Nasdaq
- Market Cap
- DERM 213.6M
- BTCS 218.2M
- IPO Year
- DERM 2021
- BTCS N/A
- Fundamental
- Price
- DERM $7.92
- BTCS $3.05
- Analyst Decision
- DERM Strong Buy
- BTCS Strong Buy
- Analyst Count
- DERM 3
- BTCS 1
- Target Price
- DERM $12.67
- BTCS $7.00
- AVG Volume (30 Days)
- DERM 256.5K
- BTCS 1.7M
- Earning Date
- DERM 11-12-2025
- BTCS 11-14-2025
- Dividend Yield
- DERM N/A
- BTCS 1.67%
- EPS Growth
- DERM N/A
- BTCS 735.16
- EPS
- DERM N/A
- BTCS 1.82
- Revenue
- DERM $59,399,000.00
- BTCS $11,724,983.00
- Revenue This Year
- DERM $26.16
- BTCS $160.41
- Revenue Next Year
- DERM $45.27
- BTCS $46.15
- P/E Ratio
- DERM N/A
- BTCS $1.65
- Revenue Growth
- DERM 2.82
- BTCS 464.28
- 52 Week Low
- DERM $3.54
- BTCS $1.25
- 52 Week High
- DERM $9.40
- BTCS $8.49
- Technical
- Relative Strength Index (RSI)
- DERM 48.07
- BTCS 40.84
- Support Level
- DERM $7.42
- BTCS $2.88
- Resistance Level
- DERM $9.40
- BTCS $3.09
- Average True Range (ATR)
- DERM 0.54
- BTCS 0.26
- MACD
- DERM -0.14
- BTCS -0.02
- Stochastic Oscillator
- DERM 27.53
- BTCS 45.77
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About BTCS BTCS Inc.
BTCS Inc. ("BTCS" or the "Company"), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ("DeFi") and traditional finance ("TradFi") mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.